Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, Molecular therapy for Cancer: Bicalutamide, an Androgen receptor antagonist, increases the expression of tumor suppressor FBXO11 via down regulation of its target gene, 27/January/2015, 22.14, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that Bicalutamide, by suppressing the expression of its target gene, it may promote the activity of tumor suppressor FBXO11. Thus, pharmacological formulations encompassing “Bicalutamide or its analogues” may be used to inhibit the progression of tumors.
Amount: $ 300
Undisclosed information: How Bicalutamide increases the expression of FBXO11.
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org
